Sweden: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Sweden

For the fourth consecutive year, the Swedish prophylactic medicaments containing insulin market recorded decline in sales value, which decreased by -3.9% to $X in 2022. In general, consumption, however, continues to indicate a mild shrinkage. Prophylactic medicaments containing insulin consumption peaked at $X in 2016; however, from 2017 to 2022, consumption remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Sweden

In 2022, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were exported from Sweden; rising by 713% compared with 2021 figures. Overall, exports, however, continue to indicate a precipitous decrease. The most prominent rate of growth was recorded in 2016 when exports increased by 15,500%. The exports peaked at X tons in 2012; however, from 2013 to 2022, the exports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin exports soared to $X in 2022. Over the period under review, exports, however, continue to indicate a dramatic slump. The pace of growth appeared the most rapid in 2016 when exports increased by 28,347%. The exports peaked at $X in 2012; however, from 2013 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

Denmark (X tons) was the main destination for prophylactic medicaments containing insulin exports from Sweden, accounting for a 96% share of total exports. It was followed by Norway (X kg), with a 2.7% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of volume to Denmark amounted to +94.7%. Exports to the other major destinations recorded the following average annual rates of exports growth: Norway (-52.6% per year) and Finland (-2.9% per year).

In value terms, Denmark ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Sweden, comprising 84% of total exports. The second position in the ranking was taken by Norway ($X), with a 13% share of total exports.

From 2012 to 2022, the average annual growth rate of value to Denmark totaled +22.5%. Exports to the other major destinations recorded the following average annual rates of exports growth: Norway (-54.2% per year) and Finland (-11.4% per year).

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, waning by -53.6% against the previous year. Over the period under review, the export price showed a abrupt contraction. The pace of growth appeared the most rapid in 2016 when the average export price increased by 82% against the previous year. Over the period under review, the average export prices attained the peak figure at $X per ton in 2017; however, from 2018 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices for the major foreign markets. In 2022, amid the top suppliers, the country with the highest price was Norway ($X per ton), while the average price for exports to Denmark ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Norway (-3.3%), while the prices for the other major destinations experienced a decline.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Sweden

After two years of decline, supplies from abroad of medicaments containing insulin but not antibiotics in measured doses increased by 7.5% to X tons in 2022. In general, imports, however, showed a noticeable reduction. The most prominent rate of growth was recorded in 2016 with an increase of 14%. Over the period under review, imports reached the maximum at X tons in 2019; however, from 2020 to 2022, imports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin imports declined to $X in 2022. Over the period under review, imports, however, showed a deep reduction. The most prominent rate of growth was recorded in 2016 with an increase of 12%. Over the period under review, imports attained the maximum at $X in 2012; however, from 2013 to 2022, imports failed to regain momentum.

Imports by Country

In 2022, Denmark (X tons) constituted the largest prophylactic medicaments containing insulin supplier to Sweden, with a 57% share of total imports. Moreover, prophylactic medicaments containing insulin imports from Denmark exceeded the figures recorded by the second-largest supplier, France (X tons), twofold. Italy (X tons) ranked third in terms of total imports with a 9.1% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from Denmark stood at -5.9%. The remaining supplying countries recorded the following average annual rates of imports growth: France (+3.4% per year) and Italy (+50.9% per year).

In value terms, Denmark ($X), France ($X) and Italy ($X) constituted the largest prophylactic medicaments containing insulin suppliers to Sweden, with a combined 98% share of total imports.

Italy, with a CAGR of +38.2%, saw the highest growth rate of the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced mixed trend patterns.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, declining by -12.8% against the previous year. Over the period under review, the import price continues to indicate a noticeable decline. The most prominent rate of growth was recorded in 2021 an increase of 32%. The import price peaked at $X per ton in 2012; however, from 2013 to 2022, import prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was France ($X per ton), while the price for Malta ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by France (-2.6%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :